These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 25465158)
1. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli. Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158 [TBL] [Abstract][Full Text] [Related]
2. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798 [TBL] [Abstract][Full Text] [Related]
3. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches. Thévenot J; Cordonnier C; Rougeron A; Le Goff O; Nguyen HT; Denis S; Alric M; Livrelli V; Blanquet-Diot S Appl Microbiol Biotechnol; 2015 Nov; 99(21):9097-110. PubMed ID: 26084888 [TBL] [Abstract][Full Text] [Related]
4. The Probiotic Bury S; Soundararajan M; Bharti R; von Bünau R; Förstner KU; Oelschlaeger TA Front Microbiol; 2018; 9():929. PubMed ID: 29896160 [TBL] [Abstract][Full Text] [Related]
5. Phylogenetic analysis and Shiga toxin production profiling of Shiga toxin-producing/enterohemorrhagic Escherichia coli clinical isolates. Li R; Harada T; Honjoh K; Miyamoto T Microb Pathog; 2010 Nov; 49(5):246-51. PubMed ID: 20558273 [TBL] [Abstract][Full Text] [Related]
6. Effect of lactoferrin on release and bioactivity of Shiga toxins from different Escherichia coli O157:H7 strains. Kieckens E; Rybarczyk J; Barth SA; Menge C; Cox E; Vanrompay D Vet Microbiol; 2017 Apr; 202():29-37. PubMed ID: 27039884 [TBL] [Abstract][Full Text] [Related]
7. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571 [TBL] [Abstract][Full Text] [Related]
8. [Construction and immunization of a enterohemorrhagic Escherichia coli O157 attenuated]. Liu J; Sun Y; Feng SZ Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):211-7. PubMed ID: 17460890 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic and genotypic traits of Shiga toxin-negative E. coli O157:H7/H(-) bovine and porcine strains. Stephan R; Zhang W; Bielaszewska M; Mellmann A; Karch H Foodborne Pathog Dis; 2009 Mar; 6(2):235-43. PubMed ID: 19245340 [TBL] [Abstract][Full Text] [Related]
10. Adaptive Radioresistance of Enterohemorrhagic Escherichia coli O157:H7 Results in Genomic Loss of Shiga Toxin-Encoding Prophages. Gaougaou G; Vincent AT; Krylova K; Habouria H; Bessaiah H; Baraketi A; Veyrier FJ; Dozois CM; Déziel E; Lacroix M Appl Environ Microbiol; 2023 Apr; 89(4):e0130622. PubMed ID: 37014232 [TBL] [Abstract][Full Text] [Related]
11. Impact of the rpoS genotype for acid resistance patterns of pathogenic and probiotic Escherichia coli. Coldewey SM; Hartmann M; Schmidt DS; Engelking U; Ukena SN; Gunzer F BMC Microbiol; 2007 Mar; 7():21. PubMed ID: 17386106 [TBL] [Abstract][Full Text] [Related]
12. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. Carey CM; Kostrzynska M; Ojha S; Thompson S J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583 [TBL] [Abstract][Full Text] [Related]
13. Subtilase contributes to the cytotoxicity of a Shiga toxin-producing Escherichia coli strain encoding three different toxins. Hauser E; Bruederle M; Reich C; Bruckbauer A; Funk J; Schmidt H Int J Food Microbiol; 2016 Jan; 217():156-61. PubMed ID: 26523884 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. Reissbrodt R; Hammes WP; dal Bello F; Prager R; Fruth A; Hantke K; Rakin A; Starcic-Erjavec M; Williams PH FEMS Microbiol Lett; 2009 Jan; 290(1):62-9. PubMed ID: 19016876 [TBL] [Abstract][Full Text] [Related]
15. A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression. Nawrocki EM; Mosso HM; Dudley EG Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32358004 [TBL] [Abstract][Full Text] [Related]
16. Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids. Pradhan S; Weiss AA mBio; 2020 Jul; 11(4):. PubMed ID: 32636253 [No Abstract] [Full Text] [Related]
17. Genotypes and virulence characteristics of Shiga toxin-producing Escherichia coli O104 strains from different origins and sources. Miko A; Delannoy S; Fach P; Strockbine NA; Lindstedt BA; Mariani-Kurkdjian P; Reetz J; Beutin L Int J Med Microbiol; 2013 Dec; 303(8):410-21. PubMed ID: 23777812 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobials effective for inhibition of enterohaemorrhagic Escherichia coli strains O26, O111, and O157 and their effects on Shiga toxin releases. Lee JH; Stein BD J Microbiol Biotechnol; 2009 Oct; 19(10):1238-43. PubMed ID: 19884786 [TBL] [Abstract][Full Text] [Related]
19. Pro-inflammatory capacity of Escherichia coli O104:H4 outbreak strain during colonization of intestinal epithelial cells from human and cattle. Stalb S; Barth SA; Sobotta K; Liebler-Tenorio E; Geue L; Menge C Int J Med Microbiol; 2018 Oct; 308(7):899-911. PubMed ID: 29937390 [TBL] [Abstract][Full Text] [Related]
20. Characterization of enterohemorrhagic Escherichia coli O157:H7 00B015: a Shiga toxin producing but virulence-attenuated isolate. Wang H; Gu J; Yu S; Zhang W; Zhu Y; Zou Q; Zhu F; Mao X Can J Microbiol; 2010 Aug; 56(8):651-6. PubMed ID: 20725127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]